Imperial College London

ProfessorDavidCarling

Faculty of MedicineInstitute of Clinical Sciences

Professor of Biochemistry
 
 
 
//

Contact

 

+44 (0)7590 250 559david.carling

 
 
//

Location

 

2.14DLMS BuildingHammersmith Campus

//

Summary

 

Publications

Journals

Constantin TA, Varela-Carver A, Greenland KK, et al., 2024, Correction: The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer., Br J Cancer

Bustraan S, Bennett J, Whilding C, et al., 2024, AMPK activation suppresses leptin expression independently of adipogenesis in primary murine adipocytes., Biochem J

McGlone ER, Siebert M, Dore M, et al., 2023, Sleeve gastrectomy causes weight-loss independent improvements in hepatic steatosis, Liver International, Vol:43, ISSN:1478-3223, Pages:1890-1900

Constantin TA, Varela-Carver A, Greenland KK, et al., 2023, The CDK7 inhibitor CT7001 (Samuraciclib) targets proliferation pathways to inhibit advanced prostate cancer, British Journal of Cancer, Vol:128, ISSN:0007-0920, Pages:2326-2337

Carling D, Bevan C, Leach D, et al., 2023, AMPK activation protects against prostate cancer by inducing a catabolic cellular state, Cell Reports, Vol:42, ISSN:2211-1247, Pages:1-21

More Publications